Blackstone Inc. - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Blackstone Inc. ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$8,350,000
-37.2%
1,000,0000.0%0.04%
-38.6%
Q2 2023$13,300,000
+14.9%
1,000,0000.0%0.06%
+21.3%
Q1 2023$11,580,000
-51.3%
1,000,000
-58.5%
0.05%
-48.9%
Q3 2020$23,802,000
+186.1%
2,411,5560.0%0.09%
+162.9%
Q2 2020$8,320,000
+12.8%
2,411,5560.0%0.04%
-35.2%
Q1 2020$7,379,000
-40.5%
2,411,5560.0%0.05%
-33.3%
Q4 2019$12,395,000
-0.4%
2,411,5560.0%0.08%
+12.5%
Q3 2019$12,444,000
-14.7%
2,411,5560.0%0.07%
-5.3%
Q2 2019$14,590,000
-16.3%
2,411,5560.0%0.08%
-10.6%
Q1 2019$17,436,000
-2.3%
2,411,5560.0%0.08%
-14.1%
Q4 2018$17,846,000
+36.8%
2,411,5560.0%0.10%
+65.0%
Q3 2018$13,047,000
+52.4%
2,411,5560.0%0.06%
+36.4%
Q2 2018$8,561,000
+1.3%
2,411,556
-41.5%
0.04%
+2.3%
Q1 2018$8,454,000
+32.8%
4,123,571
+71.0%
0.04%
+65.4%
Q4 2017$6,367,000
-49.7%
2,411,5560.0%0.03%
-66.7%
Q3 2017$12,661,000
+47.5%
2,411,5560.0%0.08%
+2.6%
Q2 2017$8,585,000
-31.1%
2,411,5560.0%0.08%
-20.0%
Q1 2017$12,468,000
+36.1%
2,411,5560.0%0.10%
+66.7%
Q4 2016$9,164,000
-57.6%
2,411,5560.0%0.06%
-54.4%
Q3 2016$21,608,000
+27.3%
2,411,5560.0%0.12%
+60.3%
Q2 2016$16,977,000
-17.2%
2,411,5560.0%0.08%
-10.3%
Q1 2016$20,498,000
-35.3%
2,411,5560.0%0.09%
-25.6%
Q4 2015$31,664,000
+258.8%
2,411,5560.0%0.12%
+317.9%
Q3 2015$8,826,000
-36.5%
2,411,5560.0%0.03%
-30.0%
Q2 2015$13,891,000
-1.4%
2,411,5560.0%0.04%
+5.3%
Q1 2015$14,083,000
-25.5%
2,411,5560.0%0.04%
-28.3%
Q4 2014$18,907,000
+59.7%
2,411,5560.0%0.05%
+51.4%
Q3 2014$11,841,000
-20.5%
2,411,5560.0%0.04%
-25.5%
Q2 2014$14,903,000
+15.5%
2,411,5560.0%0.05%
+20.5%
Q1 2014$12,902,000
+2.3%
2,411,5560.0%0.04%
-2.5%
Q4 2013$12,612,000
-5.3%
2,411,5560.0%0.04%
-64.6%
Q3 2013$13,312,000
+118.2%
2,411,5560.0%0.11%
+126.0%
Q2 2013$6,101,0002,411,5560.05%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,660,000$24,206,00011.49%
Data Collective II GP, LLC 164,249$1,495,0005.44%
Decheng Capital Management III (Cayman), LLC 1,463,872$13,321,0004.08%
SB Management Ltd 1,886,107$17,164,0003.33%
Casdin Capital, LLC 7,990,652$72,715,0003.26%
ORACLE INVESTMENT MANAGEMENT INC 1,225,395$11,151,0002.20%
Jackson Square Partners, LLC 22,542,589$205,137,0002.04%
BOURNE LENT ASSET MANAGEMENT INC 556,865$5,067,0001.59%
ARK Investment Management 27,259,521$248,062,0001.04%
Nikko Asset Management Americas, Inc. 14,021,205$127,873,0000.94%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders